【摘 要】
:
目的:探讨复发性星形细胞瘤患者再手术效果。方法:本组星形细胞瘤(Ⅲ~Ⅳ级)再手术治疗31例,与第一次手术间隔期为2~150周。再手术前Karmofsky分级(KR)为30~90,7例接受3次手术。结果:再手术后存活期为1~182周,25例KR术后1个月
论文部分内容阅读
目的:探讨复发性星形细胞瘤患者再手术效果。方法:本组星形细胞瘤(Ⅲ~Ⅳ级)再手术治疗31例,与第一次手术间隔期为2~150周。再手术前Karmofsky分级(KR)为30~90,7例接受3次手术。结果:再手术后存活期为1~182周,25例KR术后1个月较术前明显改善,术后肿瘤全切除者术后生存期较相应组明显延长。结论:再手术治疗复发性星形细胞瘤是可行的,术后KR≥60,手术间隔>6个月及术中肿瘤全切除者,可获得较好疗效
Objective: To investigate the reoperation effect of recurrent astrocytomas. METHODS: Astrocytoma (grades III-IV) were treated with reoperation in 31 patients. The interval between the first surgery and the first operation was 2 to 150 weeks. Karmofsky grading (KR) was 30 to 90 before reoperation, and 7 patients received 3 surgeries. RESULTS: The survival period after reoperation was 1 to 182 weeks. 25 cases of KR were significantly improved 1 month after surgery. The postoperative survival rate of total tumor resection was significantly longer than that of the corresponding group. Conclusion: Reoperation for recurrent astrocytoma is feasible. After operation, KR ≥ 60, surgery interval >6 months, and total resection of intraoperative tumors, better results can be obtained.
其他文献
为贯彻科技为经济建设服务的方针,加速有色金属工业的发展,提高企业的技术水平和经济效益,繁荣科技活动,搞活有色金属技术市场,经上海市科技咨询服务中心批准,上海市有色金
鞍钢上半年为确保1987年生产经营目标“1010”的全面实现,开展了“545187”炼铁系统、“77035”炼钢系统、“60155”轧钢系统和改造项目的“87415”线材热试轧、“三龙”“
目的 对人乳腺癌组织C—erbB—2(癌基因蛋白)和PCNA抗体(增殖细胞核抗原)的研究。方法 利用免疫组化技术对石蜡包埋人乳腺癌标本进行免疫组化技术研究。结果 110例标本中,C—
/IL-2,whichwasthentransfectedintohu-
/IL-2,whichwasthentransfectedintohu-
MolecularbiologyofBaret′sesophagusandesophagealcancer:roleofp53AlanG.Casson,MBChBMScFRCSCFACSSubjectheadingsesophagealneoplas...
MolecularbiologyofBaret’sesophagusandesophagealcancer:roleofp53AlanG. Casson,MBChBMScFRCSCFACSSubjectheadingsesophagealneopla
局限性良性胸膜间皮瘤罕见,作者报道1例由放疗所致。女性,65岁,22年前因左侧乳腺癌行左乳房切除术,并于左胸部及左腋部行钴放射治疗。最近X线正侧位胸片示左上胸靠后一边缘
Apoptosisanditsrelationshipwithcelproliferation,p53,Waf1p21,bcl2andcmycinesophagealcarcinogenesisstudiedwithahighriskpopul...
Apoptosisanditsrelationshipwithcelproliferation,p53,Waf1p21,bcl2andcmycinesophagealcarcinogenesisstudiedwithahighriskpopul
目的 观察FD+CF方案化疗对中晚期食管癌的疗效。方法 采用FD+CF方案化疗,完成2周期以上评定疗效、毒性。结果 27例中CR2例,PR13例,总有效率55.6%。结论 FD+CF方案治疗中晚期食
作者研究49例病人的79个病灶,其中36例HCC(男25例,女11例),年龄41~80岁,而13例血管瘤年龄36~75岁。36例HCC癌灶大小为8~40mm(平均19.9mm),其中原发性癌灶32个,转移性癌灶19个。
照相铜板使用近三十年来,国内外一直沿用贵金属银为主要添加元素,以致成本高,用户长期反映的二大问题一直得不到解决:一、“铜筋”,又称麻点,为沿轧制方向的链状物,经制版腐